Chongqing Zhifei Biological Products financials at a glance

+ Portfolio

The revenue of Chongqing Zhifei Biological Products is reported as 52.91777 billion Yuan Renminbi in the fiscal year 2023. The earnings were 3.3 Yuan Renminbi per share in 2023, which was 5.43 higher than 2022. And about 7.8622 billion Yuan Renminbi are reported as free cash flow in the financials of Chongqing Zhifei Biological Products 2023. Dividends of 0.8 Yuan Renminbi per share were paid to shareholders of Chongqing Zhifei Biological Products stock SZSE:300122 in fiscal 2023.

¥52.92B

Revenue

¥3.30

Earnings Per Share

26.31%

Gross Margin %

¥9.72B

Free Cash Flow

Revenue

52,917.77

Earnings Per Share

3.30

Gross Margin %

26.31

Free Cash Flow

9,724.97

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2013	2012	2011	2010
Rev.	Revenue	N/A	¥52.92B	¥38.26B	¥30.65B	¥15.19B	¥10.59B	¥5.23B	¥780.18M	¥764.62M	¥628.74M	¥737.31M
GM %	Gross Margin %	29.39%	26.31%	33.31%	48.69%	38.67%	41.83%	54.45%	56.97%	55.11%	59.72%	63.36%
OM	Operating Margin	19.89%	17.40%	22.73%	38.90%	26.41%	27.07%	32.89%	15.69%	23.79%	24.61%	39.14%
EPS	Earnings Per Share	¥3.53	¥3.30	¥3.13	¥4.24	¥1.38	¥1.00	¥0.60	¥0.05	¥0.08	¥0.07	¥0.11
Div.	Dividends	N/A	¥0.80	¥0.33	¥0.40	¥0.33	¥0.33	¥0.33	¥0.03	¥0.00	¥0.04	¥0.00
PR %	Payout Ratio %	0	24.24%	10.54%	9.43%	23.91%	33.00%	55.00%	60.00%	0	57.14%	0
Sha.	Shares	N/AM	2,400M	2,400M	2,400M	2,400M	2,400M	2,400M	2,400M	2,400M	2,400M	2,400M
OCF	Operating Cash Flow	N/A	¥9.00B	¥1.99B	¥8.51B	¥3.50B	¥1.37B	¥585.59M	¥221.58M	¥112.89M	¥221.25M	¥54.19M
FCF	Free Cash Flow	N/A	¥9.72B	¥536.58M	¥6.58B	¥2.67B	¥794.26M	¥106.46M	¥20.21M	¥-86.17M	¥-88.31M	¥2.68M
FCFS	Free Cash Flow Per Share	¥1.03	¥3.28	¥0.22	¥2.74	¥1.67	¥0.50	¥0.07	¥0.01	¥-0.05	¥-0.06	¥0.00

Chongqing Zhifei Biological Products financials at a glance

Financials

Discover